New GM to drive market expansion

After 23 years at Johnson & Johnson, Susan Martin has a new role, at a new company and a new mission - tasked with expanding access to genomic technologies as precision medicine broadens its footprint across Australian healthcare.

Martin, who spent seven years as Managing Director at J&J MedTech, is the new ANZ Country Leader for DNA sequencing giant, Illumina and will lead the company's commercial growth, strategic partnerships, market expansion and customer success across the research, clinical, and public health sectors.

"ANZ is a key market for Illumina, and we remain focused on supporting our customers and expanding access to genomics across the region," Martin told Pharma in Focus.